Y. Suzuki

发表

Mitogen-activated protein kinase and p70 ribosomal protein S6 kinase are not involved in the insulin-dependent stimulation of cAMP phosphodiesterase kinase in rat adipocytes.

H. Onuma, H. Makino, H. Osawa, 1998, Biochimica et biophysica acta.

Insulin-stimulated phosphorylation of recombinant pp120/HA4, an endogenous substrate of the insulin receptor tyrosine kinase.

D. Accili, Simeon I. Taylor, S. Taylor, 1995, Biochemistry.

Mutations in the insulin receptor gene.

D. Accili, M. Quon, M. de la Luz Sierra, 1992, Endocrine reviews.

Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus.

D. Accili, G. Sesti, S. Taylor, 1994, The Journal of clinical endocrinology and metabolism.

A missense mutation in the CD38 gene, a novel factor for insulin secretion: association with Type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro

S. Takasawa, H. Okamoto, H. Makino, 1998, Diabetologia.

Increased activity and expression of MAP kinase in HCC model rats induced by 3'-methyl-4-dimethylamino-azobenzene.

O. Yokosuka, B. Goldstein, Y. Suzuki, 1999, Journal of hepatology.

Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.

Y. Suzuki, Y. Saito, K. Yagui, 2006, Diabetes research and clinical practice.

A Synthetic Peptide Corresponding to the Rab4 Hypervariable Carboxyl-terminal Domain Inhibits Insulin Action on Glucose Transport in Rat Adipocytes (*)

Y. Suzuki, H. Shibata, W. Omata, 1996, The Journal of Biological Chemistry.

Insulin receptor gene mutation: a molecular genetical and functional analysis.

H. Makino, Y. Suzuki, M. Taira, 1992, Cellular signalling.

Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor.

Y. Ebina, H. Makino, Y. Suzuki, 1989, Science.

Activation of mouse phosphodiesterase 3B gene promoter by adipocyte differentiation in 3T3‐L1 cells

Kazuya Yamada, H. Onuma, H. Makino, 2001, FEBS letters.

A glycine-1008 to valine mutation in the insulin receptor in a woman with type A insulin resistance.

H. Makino, Y. Suzuki, M. Taira, 1993, The Journal of clinical endocrinology and metabolism.

Mechanisms of hormone resistance: lessons from insulin‐resistant patients

D. Accili, M. Quon, C. Haft, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Analysis of the insulin-sensitive phosphodiesterase 3B gene in type 2 diabetes.

H. Makino, Y. Suzuki, M. Taira, 2001, Diabetes research and clinical practice.

Defects in insulin binding and receptor kinase in cells from a woman with type A insulin resistance and from her family

H. Makino, Y. Suzuki, M. Taira, 1991, Diabetologia.

Mutations in the Hepatocyte Nuclear Factor-4α Gene in Japanese with Non-Insulin-Dependent Diabetes: A Nucleotide Substitution in the Polypyrimidine Tract of Intron 1b

T. Egashira, H. Makino, Y. Suzuki, 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Preventive effect of sulphated colominic acid on P‐selectin‐dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis

Y. Suzuki, H. Makino, S. Okada, 2002, Clinical and experimental immunology.

Tumor necrosis factor alpha signaling pathway and apoptosis in pancreatic beta cells.

J. Miyazaki, H. Makino, Y. Suzuki, 1999, Metabolism: clinical and experimental.

Insulin-resistant diabetes associated with partial deletion of insulin-receptor gene

Y. Ebina, Y. Suzuki, M. Taira, 1990, The Lancet.

Expression of a cDNA encoding the human insulin receptor-related receptor.

D. Accili, S. Taylor, Y. Suzuki, 1994, The Journal of biological chemistry.

Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial

Y. Tomino, S. Araki, M. Haneda, 2009, Diabetologia.

Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor

Y. Ebina, H. Makino, Y. Suzuki, 1989 .

Insulin resistance associated with decreased levels of insulin-receptor messenger ribonucleic acid: evidence of a de novo mutation in the maternal allele.

S. Taylor, H. Makino, Y. Suzuki, 1995, The Journal of clinical endocrinology and metabolism.

Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance

H. Makino, Y. Suzuki, M. Taira, 1992, Diabetologia.

L-selectin and its ligands mediate infiltration of mononuclear cells into kidney interstitium after ureteric obstruction.

Y. Suzuki, H. Makino, M. Miyasaka, 1999, The Journal of pathology.

Two naturally occurring mutations in the kinase domain of insulin receptor accelerate degradation of the insulin receptor and impair the kinase activity.

T. Imamura, T. Sasaoka, T. Haruta, 1994, The Journal of biological chemistry.

The Dipeptidyl Peptidase-4 Inhibitor Vildagliptin has the Capacity to Repair β-Cell Dysfunction and Insulin Resistance

Y. Suzuki, A. Kanatsuka, M. Sunaga, 2014, Hormone and Metabolic Research.